Home
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

NCT00002816

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Long Beach Memorial Medical Center Long Beach, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 33 locations

View Trial Details

Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00304018

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +45 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00967057

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Women's and Children's Hospital North Adelaide, South Australia, Australia

Birmingham Children's Hospital Birmingham, England, United Kingdom

Bristol Royal Hospital for Children Bristol, England, United Kingdom

Great Ormond Street Hospital for Children London, England, United Kingdom

View Trial Details

Completed

Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

NCT00002576

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
Locations: Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom

View Trial Details

Completed

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

NCT00005590

Conditions: Adnexal Diseases, Brain and Central Nervous System Tumors, Breast Cancer, +83 more
Locations: University of Birmingham Birmingham, England, United Kingdom

View Trial Details

Completed

Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

NCT00795886

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Primary Children's Medical Center Salt Lake City, Utah, United States

View Trial Details

Completed

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

NCT00006340

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
Locations: Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States

Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Hopital Necker Paris, France

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00054327

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

NCT00049686

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

3-AP and Cytarabine in Treating Patients With Hematologic Cancer

NCT00064090

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +33 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions